ALGNALIGN TECHNOLOGY INC
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $4.0B
- 0.9% YoY
- Operating margin
- 13.5%
- 11% YoY
- EBITDA
- $783M
- 4.1% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear145% of net incomeCash flow under 80% of net income
- Dilutive SBCClear5% of revenueOver 10% of revenue
- Payouts exceed cash flowClear79% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear8% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $4.0B | $3.7B | $3.9B | $4.0B | $4.0B | 0.9% |
| Operating income | $976M | $643M | $643M | $608M | $546M | 10% |
| Net income | $772M | $362M | $445M | $421M | $410M | 2.6% |
| Operating cash flow | $1.2B | $569M | $786M | $738M | $593M | 20% |
| Capex | $401M | $292M | $178M | $116M | $102M | 11% |
| Stock-based comp | $114M | $133M | $154M | $174M | $186M | 7.0% |
| Buybacks | $375M | $435M | $592M | $353M | $466M | 32% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $19M | $4M | 29 | 117 |
| FY2024 | $27M | $5M | 39 | 110 |
| FY2023 | $29M | $29M | 51 | 100 |
| FY2022 | $19M | −$61M | 39 | 93 |
| FY2021 | $22M | $76M | 123 | 119 |